August 4, 2022
PAR-22-181 - NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
NOT-NR-22-016 - Notice of theNINR's Participation in PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
The purpose of this notice is to inform applicants of a change to the title of PAR-22-181 "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)". Specifically, the title has been changed to reflect the National Institute of Nursing Research's (NINR) participation in this Funding Opportunity Announcement (FOA). The title has been changed to "NIDA, NIMH, NINR and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional).
Currently Reads:
Part 1. Overview Information:
Funding Opportunity Title: NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
Modified to Read:
Part 1. Overview Information
Funding Opportunity Title: NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
All other aspects of this FOA remain unchanged.
Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email: [email protected]